0
Your Basket is Empty

Coronavirus Research Products

 

Coronavirus SARS-CoV-2, also known as COVID-19, is a global healthcare threat that has expanded across the globe in early 2020 in a matter of months, causing high numbers of deaths. The global scientific community has been working at incredible speed to deliver therapeutics and vaccines to limit the consequences of this aggressive virus.

Biosynth Carbosynth is proud to support the Coronavirus research with small molecules that have documented activity against Coronaviruses.

Giving the urgent nature of the Coronavirus research, products highlighted here are IN STOCK and available for immediate shipping.

The products below are relevant to antiviral research and have been cited in relation to SARS-CoV-2 and closely related viruses. 

 

Coronavirus research products

 
Viral entry into host cells
Losartan potassium
Camostat mesylate
Arbidol / Umifenovir
Baricitinib
 
 
Viral RNA transcription and replication
Remdesivir / GS 5734
Ribavirin
GS 441524
GS 441524 triphosphate - Coming soon
Penciclovir
Nitazoxanide
Favipiravir
Baloxavir marboxil - Coming soon
Pimodivir - Coming soon
EIDD 2801 - Coming soon
Triazavirin - Coming soon
 
 
Viral assembly and maturation
Ritonavir
Lopinavir
Darunavir
N-Butyldeoxynojirimycin
ASC 09 - Coming soon
 
 
Immune response modulation
Chloroquine
Chloroquine diphosphate
Hydroxychloroquine sulfate
Disulfiram
Fingolimod
Fingolimod HCl
Ruxolitinib
Thalidomide
Tocilizumab - Coming soon
 
 
Other
Cobicistat
 Melatonin
 

*For research use only. Not for human and veterinary use. More information can be found in General Terms and Conditions.

 

For our full offering of antiviral products, see here.

 

NEWS AND ARTICLES 

If you would like to read about recent research on the promising approaches to combat the SARS-CoV-2 virus, click through the topics below: 

 

Remdesivir: The molecular biology behind its anti-coronavirus activity (01-04-2020)

Remdesivir, also known by it's developmental name GS 5734, is a nucleoside prodrug with a broad spectrum antiviral activity against RNA viruses. 

 

Protease inhibitor Camostat Mesylate inhibits coronavirus entry in cells (26-03-2020)

Inhibition of a specific cellular protease by camostat mesylate results in lower SARS-CoV-2 infectivity.

 

Nucleoside analogues as therapy for coronavirus infections (20-03-2020)

Nucleoside and nucleotide analogs are an exciting avenue for development of antiviral agents. 

 

Antiviral antimetabolite Ribavirin (19-03-2020)

Repurposing Ribavirin against COVID-19. Read more about the potential effectiveness of Ribavirin against the Coronavirus

 

The role of glycans in coronavirus infection (16-03-2020)

The role of glycans on the spike glycoprotein from SARS-CoV-2. Research on a closely related virus shows the involvement of N-glycans in the early stages of infection.

 

 We also offer products for Coronavirus Diagnostics.


Please Wait...